Enterprise Value
4.758M
Cash
153.7M
Avg Qtr Burn
-6.086M
Short % of Float
1.26%
Insider Ownership
5.45%
Institutional Own.
12.64%
Qtr Updated
03/31/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
ORMD-0801 (ORA-D-013-1) Details Diabetes, Type 2 diabetes | Phase 3 Update | |
ORMD-0801 Details Non-alcoholic steatohepatitis , Liver disease | Phase 2 Update |